BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28381396)

  • 41. The ordered acquisition of Class II and Class I mutations directs formation of human t(8;21) acute myelogenous leukemia stem cell.
    Shima T; Miyamoto T; Kikushige Y; Yuda J; Tochigi T; Yoshimoto G; Kato K; Takenaka K; Iwasaki H; Mizuno S; Goto N; Akashi K
    Exp Hematol; 2014 Nov; 42(11):955-65.e1-5. PubMed ID: 25101977
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dominant negative effects of the AML1/ETO fusion oncoprotein.
    Fenske TS; Pengue G; Graubert TA
    Cell Cycle; 2005 Jan; 4(1):33-6. PubMed ID: 15611635
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The lncRNA HOTAIRM1 regulates the degradation of PML-RARA oncoprotein and myeloid cell differentiation by enhancing the autophagy pathway.
    Chen ZH; Wang WT; Huang W; Fang K; Sun YM; Liu SR; Luo XQ; Chen YQ
    Cell Death Differ; 2017 Feb; 24(2):212-224. PubMed ID: 27740626
    [TBL] [Abstract][Full Text] [Related]  

  • 44. AML1-ETO fusion protein up-regulates TRKA mRNA expression in human CD34+ cells, allowing nerve growth factor-induced expansion.
    Mulloy JC; Jankovic V; Wunderlich M; Delwel R; Cammenga J; Krejci O; Zhao H; Valk PJ; Lowenberg B; Nimer SD
    Proc Natl Acad Sci U S A; 2005 Mar; 102(11):4016-21. PubMed ID: 15731354
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genome-wide studies identify a novel interplay between AML1 and AML1/ETO in t(8;21) acute myeloid leukemia.
    Li Y; Wang H; Wang X; Jin W; Tan Y; Fang H; Chen S; Chen Z; Wang K
    Blood; 2016 Jan; 127(2):233-42. PubMed ID: 26546158
    [TBL] [Abstract][Full Text] [Related]  

  • 47. AML1-ETO reprograms hematopoietic cell fate by downregulating scl expression.
    Yeh JR; Munson KM; Chao YL; Peterson QP; Macrae CA; Peterson RT
    Development; 2008 Jan; 135(2):401-10. PubMed ID: 18156164
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Loss of Dnmt3a and endogenous Kras(G12D/+) cooperate to regulate hematopoietic stem and progenitor cell functions in leukemogenesis.
    Chang YI; You X; Kong G; Ranheim EA; Wang J; Du J; Liu Y; Zhou Y; Ryu MJ; Zhang J
    Leukemia; 2015 Sep; 29(9):1847-56. PubMed ID: 25801914
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting autophagy potentiates the apoptotic effect of histone deacetylase inhibitors in t(8;21) AML cells.
    Torgersen ML; Engedal N; Bøe SO; Hokland P; Simonsen A
    Blood; 2013 Oct; 122(14):2467-76. PubMed ID: 23970379
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Homoharringtonine synergy with oridonin in treatment of t(8; 21) acute myeloid leukemia.
    Zhang W; Lu Y; Zhen T; Chen X; Zhang M; Liu P; Weng X; Chen B; Wang Y
    Front Med; 2019 Jun; 13(3):388-397. PubMed ID: 30206768
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The multi-functional cellular adhesion molecule CD44 is regulated by the 8;21 chromosomal translocation.
    Peterson LF; Wang Y; Lo MC; Yan M; Kanbe E; Zhang DE
    Leukemia; 2007 Sep; 21(9):2010-9. PubMed ID: 17657222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. AML1-ETO9a is correlated with C-KIT overexpression/mutations and indicates poor disease outcome in t(8;21) acute myeloid leukemia-M2.
    Jiao B; Wu CF; Liang Y; Chen HM; Xiong SM; Chen B; Shi JY; Wang YY; Wang JH; Chen Y; Li JM; Gu LJ; Tang JY; Shen ZX; Gu BW; Zhao WL; Chen Z; Chen SJ
    Leukemia; 2009 Sep; 23(9):1598-604. PubMed ID: 19458628
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glucocorticoids Inhibit Oncogenic RUNX1-ETO in Acute Myeloid Leukemia with Chromosome Translocation t(8;21).
    Lu L; Wen Y; Yao Y; Chen F; Wang G; Wu F; Wu J; Narayanan P; Redell M; Mo Q; Song Y
    Theranostics; 2018; 8(8):2189-2201. PubMed ID: 29721072
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cell-intrinsic depletion of Aml1-ETO-expressing pre-leukemic hematopoietic stem cells by K-Ras activating mutation.
    Di Genua C; Norfo R; Rodriguez-Meira A; Wen WX; Drissen R; Booth CAG; Povinelli B; Repapi E; Gray N; Carrelha J; Kettyle LM; Jamieson L; Neo WH; Thongjuea S; Nerlov C; Mead AJ
    Haematologica; 2019 Nov; 104(11):2215-2224. PubMed ID: 30975913
    [TBL] [Abstract][Full Text] [Related]  

  • 55. VENTX induces expansion of primitive erythroid cells and contributes to the development of acute myeloid leukemia in mice.
    Gentner E; Vegi NM; Mulaw MA; Mandal T; Bamezai S; Claus R; Tasdogan A; Quintanilla-Martinez L; Grunenberg A; Döhner K; Döhner H; Bullinger L; Haferlach T; Buske C; Rawat VP; Feuring-Buske M
    Oncotarget; 2016 Dec; 7(52):86889-86901. PubMed ID: 27888632
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Suppressed translation and ULK1 degradation as potential mechanisms of autophagy limitation under prolonged starvation.
    Allavena G; Boyd C; Oo KS; Maellaro E; Zhivotovsky B; Kaminskyy VO
    Autophagy; 2016 Nov; 12(11):2085-2097. PubMed ID: 27629431
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A FOXO1-induced oncogenic network defines the AML1-ETO preleukemic program.
    Lin S; Ptasinska A; Chen X; Shrestha M; Assi SA; Chin PS; Imperato MR; Aronow BJ; Zhang J; Weirauch MT; Bonifer C; Mulloy JC
    Blood; 2017 Sep; 130(10):1213-1222. PubMed ID: 28710059
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genome-wide co-occupancy of AML1-ETO and N-CoR defines the t(8;21) AML signature in leukemic cells.
    Trombly DJ; Whitfield TW; Padmanabhan S; Gordon JA; Lian JB; van Wijnen AJ; Zaidi SK; Stein JL; Stein GS
    BMC Genomics; 2015 Apr; 16(1):309. PubMed ID: 25928846
    [TBL] [Abstract][Full Text] [Related]  

  • 59. AML1/ETO trans-activates c-KIT expression through the long range interaction between promoter and intronic enhancer.
    Tian Y; Wang G; Hu Q; Xiao X; Chen S
    J Cell Biochem; 2018 Apr; 119(4):3706-3715. PubMed ID: 29236325
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes.
    Pattabiraman DR; McGirr C; Shakhbazov K; Barbier V; Krishnan K; Mukhopadhyay P; Hawthorne P; Trezise A; Ding J; Grimmond SM; Papathanasiou P; Alexander WS; Perkins AC; Levesque JP; Winkler IG; Gonda TJ
    Blood; 2014 Apr; 123(17):2682-90. PubMed ID: 24596419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.